Page 119 - Genentech News Today

BNTX earnings call for the period ending June 30, 2023.

A major drug pricing crackdown in the US is threatening drug companies’ bottom lines.

JACKSON, Miss. (WJTV) - A national bio-tech company, Genentech, announced that a Mississippi based community organization is among 10 chosen to share a $6 million grant. All of the organizations are working to advance health equity by improving the conditions in their communities that affect health and wellbeing. Jackson-based Southern Echo will begin by reaching [...]

Patients taking glucagon-like peptide-1 agonists were more likely to progress from nonproliferative diabetic retinopathy to proliferative disease or diabetic macular edema than those who took sodium-glucose cotransporter-2 inhibitors.

/PRNewswire/ -- The "Cell Therapy Clinical Activity and Process Automation" report has been added to ResearchAndMarkets.coms offering. Cell therapy, a...

Structure Therapeutics announced that it has appointed Ted W. Love, M.D., to its Board of Directors

04.08.2023 - AC Immune Reports Second Quarter 2023 Financial Results and Provides a Corporate Update Received FDA Fast Track Designation for ACI-24.060 anti-amyloid-beta (Abeta) active immunotherapy to treat Alzheimer’s disease (AD)Enrollment in ongoing Phase ...

Operator: Good day, and thank you for standing by. Welcome to the Adaptive Biotechnologies Second Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode.

/PRNewswire/ -- The "US Orphan Drugs Market, Drugs Sales, Price, Dosage & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.coms...

Operator: Thank you for standing by, and welcome to the Nautilus Biotechnology Second Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, todays program is being recorded.